Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
SG

SARAH GILBERT

CGCN GROUP, LLC · Washington, DC
Registered · LDAActive

Background

Career
Washington, DC · current
Government experience
(3) Legislative Correspondent
Rep. George Holding, Nov. 2017-Aug. 2018; Staff Assistant, Rep. George Holding, Dec. 2016-Nov. 2017
(4) Intern
Rep. George Holding, Aug. 2016-Dec 2016; Intern, Sen. Richard Burr, June 2016-July 2016
Covered official positions, as disclosed on federal filings

The past 12 months

Clients
8
past 12 months
Filings
8
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATEWhite House OfficeHealth & Human Services, Dept of (HHS)Commerce, Dept of (DOC)Environmental Protection Agency (EPA)Homeland Security, Dept of (DHS)

Specific issues

Discussions concerning the FY 2025 and FY 2026 appropriations bills; provisions related to the FDA regulation of tobacco.
Budget/Appropriations · 2026 Q2
Implementation of P.L. 111-31, the Tobacco Control Act; Issues surrounding FDA PMTA and MRTP compliance policies; Issues surrounding tobacco harm reduction; Issues surrounding efforts to prevent youth access to tobacco products; Discussions in support of the regulation of products containing synthetic nicotine and disposable e-cigarettes; Issues surrounding increased scrutiny on FDA/CTP for delayed enforcement; Issues surrounding CBP resources for interdicting massive influx & mislabeling illicit vapes; Issues surrounding retail inspections enforcement limitation; Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act; NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes; January 2025 Proposed Rule: Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products; Issues surrounding efforts to prevent youth access to tobacco products; Discussions regarding federal excise taxes and the taxation of tobacco products; Discussions regarding FDA enforcement of flavored disposable e-cigarettes and PMTA transparency.
Tobacco · 2026 Q2
Issues surrounding prevention of illicit tobacco, patents, tariffs, duty and customs, Free Trade Agreements (FTAs); HR 1, THE ONE BIG BEAUTIFUL BILL
Trade (domestic/foreign) · 2026 Q2
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act; S. 2929/H.R. 5715, Tobacco Tax Equity Act; Issues surrounding Internal Revenue Code 420; Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings; Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products; Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes; Issues surrounding taxation of tobacco products.
Taxation/Internal Revenue Code · 2026 Q2
Issues related to consumer motor vehicle parts; the advancement of repair options for vehicle technology components and systems to improve safety of motor vehicles, auto parts supply chains, and importation.
Automotive Industry · 2026 Q2
Buy America legislation, tariffs, and tax incentives.
Manufacturing · 2026 Q2

Clients

2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings8
2026 Q2
RAI SERVICES COMPANY
Q2lda.gov →
2026 Q2
THE MOTOR & EQUIPMENT MANUFACTURERS ASSOCIATION
Q2lda.gov →
2026 Q2
TEXAS ESSENTIAL HEALTHCARE PARTNERSHIPS
Q2lda.gov →
2026 Q2
VERTEX PHARMACEUTICALS INCORPORATED
Q2lda.gov →
2026 Q2
PARKVIEW HEALTH SYSTEM, INC.
Q2lda.gov →
2026 Q2
RELX INC.
Q2lda.gov →
2026 Q2
FRESENIUS KABI USA, LLC
Q2lda.gov →
2026 Q2
FUJIFILM HOLDINGS AMERICA CORPORATION
Q2lda.gov →